{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:39:09Z","timestamp":1648928349738},"reference-count":11,"publisher":"Japanese Urological Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5980\/jpnjurol.105.91","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T22:05:30Z","timestamp":1438639530000},"page":"91-96","source":"Crossref","is-referenced-by-count":0,"title":["RISK FACTORS OF RECURRENCE AFTER RADICAL PROSTATECTOMY FOR LOCALLY ADVANCED PROSTATE CANCER"],"prefix":"10.5980","volume":"105","author":[{"given":"Yoshiyuki","family":"Yamamoto","sequence":"first","affiliation":[{"name":"The Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nakayama","sequence":"additional","affiliation":[{"name":"The Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norichika","family":"Ueda","sequence":"additional","affiliation":[{"name":"The Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Takeda","sequence":"additional","affiliation":[{"name":"The Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Nakata","sequence":"additional","affiliation":[{"name":"The Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Arai","sequence":"additional","affiliation":[{"name":"The Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Kakimoto","sequence":"additional","affiliation":[{"name":"The Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Nishimura","sequence":"additional","affiliation":[{"name":"The Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","unstructured":"1) NCCN Clinical Practice Guidelines in Oncology, Prostate Cancer. PROS-4, Version2, 2012. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf"},{"key":"2","unstructured":"2) EAU Guidelines on Prostate Cancer. 47-51, 2012. http:\/\/www.uroweb.org\/gls\/pdf\/08%20Prostate%20Cancer_LR%20March%2013th%202012.pdf"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Ward JF, Slezak JM, Blute ML, Bergstralh EJ and Zincke H: Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int, 95, 751-756, 2005.","DOI":"10.1111\/j.1464-410X.2005.05394.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Carver BS, Bianco FJ Jr, Scardino PT and Eastham JA: Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. J Urol, 176, 564-568, 2006.","DOI":"10.1016\/j.juro.2006.03.093"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Hsu CY, Joniau S, Oyen R, Roskams T and Van Poppel H: Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur Urol, 51, 121-129, 2007.","DOI":"10.1016\/j.eururo.2006.05.024"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, deVere White R, Hemstreet GP 3rd, Crawford ED, Thompson IM Jr and Klein EA: Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109. Urology, 79, 633-637, 2012.","DOI":"10.1016\/j.urology.2011.11.019"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8) Xylinas E, Drouin SJ, Comperat E, Vaessen C, Renard-Penna R, Misrai V, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O and Roupret M: Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience. BJU Int, 103, 1173-1178, 2008.","DOI":"10.1111\/j.1464-410X.2008.08208.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Brehmer B, Borchers H, Kirschner-Hermanns R, Biesterfeld S and Jakse G: Perioperative morbidity of the extended radical perineal prostatectomy. Eur Urol, 40, 139-143, 2001.","DOI":"10.1159\/000049764"},{"key":"9","doi-asserted-by":"crossref","unstructured":"11) Schumacher MC, Burkhard FC, Thalmann GN, Fleischmann A and Studer UE: Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol, 54, 344-352, 2008.","DOI":"10.1016\/j.eururo.2008.05.023"},{"key":"10","doi-asserted-by":"crossref","unstructured":"12) Shelley MD, Kumar S, Wilt T, Staffurth J, Coles B and Mason MD: A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma. Cancer Treat Rev, 35, 9-17, 2009.","DOI":"10.1016\/j.ctrv.2008.08.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"13) Klotz LH, Goldenberg SL, Jewett MA, Fradet Y, Nam R, Barkin J, Chin J and Chatterjee S: Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy. J Urol, 170, 791-794, 2003.","DOI":"10.1097\/01.ju.0000081404.98273.fd"}],"container-title":["The Japanese Journal of Urology"],"original-title":["\u5c40\u6240\u9032\u884c\u6027\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u6839\u6cbb\u7684\u524d\u7acb\u817a\u5168\u6458\u9664\u8853\u306e\u8853\u5f8c\u518d\u767a\u56e0\u5b50\u306b\u95a2\u3059\u308b\u691c\u8a0e"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/105\/3\/105_91\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T01:19:52Z","timestamp":1567041592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/105\/3\/105_91\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.105.91","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}